What The Health with Emily Casey The A$2.2B Myricx Bio Deal, AI's Healthcare Land Grab and Preventive Health
With Jackie Rabec
Prashanth Rajan is an Associate at Brandon Capital, Australia's largest life sciences venture capital firm, where he leads New South Wales activities from its Sydney office and has worked on due diligence for investments including Pheon Therapeutics and Advancell Isotopes. He joined Brandon Capital in 2021 after serving as Senior Commercialisation Manager at UniSA Ventures, the University of South Australia's commercialisation arm, and as operations manager for portfolio company AbRegen. Rajan holds a PhD in biochemistry and molecular biology from the University of Queensland. On What The Health, he discussed the A$2.2 billion Myricx Bio deal and AI's growing role in healthcare.
1 episode
Key moments from The A$2.2B Myricx Bio Deal, AI's Healthcare Land Grab and Preventive Health.
Associate · Brandon Capital
Senior Commercialisation Manager · UniSA Ventures
Operations Manager · AbRegen
Sources: brandoncapital.vc
Brandon Capital is a Melbourne-based venture capital firm that invests in life sciences companies from seed stage through to expansion.
2 people · 2 episodes
Spot something wrong? Suggest a correctionUpdated 25 September 2026
Put your brand alongside the voices founders, investors and operators come to hear.
Explore sponsorshipW2D1 Media — the team behind the Day One Network, which helped build Blackbird Ventures' Wild Hearts — builds and produces podcasts for funds, founders and operators. If you want a show built around your brand, let's talk.